HONASA - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.8
| Stock Code | HONASA | Market Cap | 12,514 Cr. | Current Price | 385 ₹ | High / Low | 403 ₹ |
| Stock P/E | 64.3 | Book Value | 42.9 ₹ | Dividend Yield | 0.00 % | ROCE | 18.5 % |
| ROE | 15.0 % | Face Value | 10.0 ₹ | DMA 50 | 331 ₹ | DMA 200 | 303 ₹ |
| Chg in FII Hold | -0.88 % | Chg in DII Hold | 0.60 % | PAT Qtr | 64.5 Cr. | PAT Prev Qtr | 51.7 Cr. |
| RSI | 65.6 | MACD | 7.98 | Volume | 13,70,848 | Avg Vol 1Wk | 6,90,323 |
| Low price | 248 ₹ | High price | 403 ₹ | PEG Ratio | 1.08 | Debt to equity | 0.08 |
| 52w Index | 88.4 % | Qtr Profit Var | 162 % | EPS | 5.87 ₹ | Industry PE | 44.2 |
📊 Core Financials
- Revenue Growth: Quarterly PAT rose to ₹64.5 Cr from ₹51.7 Cr, showing strong 162% YoY growth.
- Profit Margins: ROE at 15.0% and ROCE at 18.5% indicate moderate profitability.
- Debt Ratios: Debt-to-equity of 0.08 reflects low leverage.
- Cash Flows: Dividend yield of 0.00% provides no shareholder income.
- Return Metrics: EPS of ₹5.87 shows limited earnings power relative to valuation.
💹 Valuation Indicators
- P/E Ratio: 64.3 vs industry PE of 44.2, suggesting premium valuation.
- P/B Ratio: Price ₹385 vs book value ₹42.9, trading at ~9.0x book.
- PEG Ratio: 1.08, indicating fair valuation relative to growth.
- Intrinsic Value: Current price above DMA 50 (₹331) and DMA 200 (₹303), showing strong momentum.
🏢 Business Model & Competitive Advantage
Honasa Consumer (HONASA), parent of Mamaearth and other personal care brands, operates in FMCG with a focus on natural, sustainable, and digital-first products. Its competitive advantage lies in strong brand recall, e-commerce-driven distribution, and innovation in personal care. However, profitability remains modest compared to high valuations.
📈 Entry Zone & Long-Term Guidance
Entry zone looks reasonable around ₹360–₹380 given RSI (65.6) showing near overbought levels. Long-term holding is viable due to strong brand positioning and growth potential, though valuations remain stretched and dividend yield is absent.
✅ Positive
- Strong PAT growth (162%).
- Low debt-to-equity ratio (0.08) ensures financial stability.
- Stock trading above DMA 200, reflecting strong momentum.
⚠️ Limitation
- P/E ratio (64.3) above industry average (44.2), suggesting overvaluation.
- No dividend yield, limiting shareholder income.
- EPS of ₹5.87 is modest compared to valuation multiples.
📉 Company Negative News
- FII holding decreased (-0.88%), showing reduced foreign investor confidence.
- Valuation multiples remain high relative to earnings power.
📈 Company Positive News
- DII holding increased (+0.60%), showing domestic institutional support.
- Quarterly PAT surged from ₹51.7 Cr to ₹64.5 Cr.
🏭 Industry
The FMCG industry in India is resilient, driven by rising consumption, premiumization, and digital distribution. Industry PE at 44.2 is lower than HONASA’s 64.3, suggesting relative overvaluation. Competition is intense, but HONASA benefits from niche positioning in natural and sustainable personal care.
🔎 Conclusion
HONASA demonstrates strong growth and brand strength but trades at premium valuations with modest profitability. Entry around ₹360–₹380 is reasonable for growth-focused investors. Long-term holding is recommended for brand-driven expansion, though caution is advised due to high valuation multiples and lack of dividend yield.
Would you like me to also compare HONASA with peers like Hindustan Unilever, Dabur, and Emami to evaluate relative positioning in the FMCG and personal care sector?